Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma. | Oncogene;26(13): 1920-31, 2007 Mar 22. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma.

Lau, L; Hansford, L M; Cheng, L S; Hang, M; Baruchel, S; Kaplan, D R; Irwin, M S.

Affiliation

Lau L; Division of Hematology/Oncology, Cancer Research Program, Hospital for Sick Children, Toronto, Canada.

Oncogene ; 26(13): 1920-31, 2007 Mar 22.

Article in En | MEDLINE | ID: mdl-16983334

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Cyclooxygenase Inhibitors / Apoptosis / Proto-Oncogene Proteins c-mdm2 / Neuroblastoma / Antineoplastic Agents Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2007 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Cyclooxygenase Inhibitors / Apoptosis / Proto-Oncogene Proteins c-mdm2 / Neuroblastoma / Antineoplastic Agents Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2007 Document type: Article Affiliation country: